Over 85 firms are involved in providing fragment-based drug discovery-related services; of these, around 40 players claim to offer both libraries and technologies

Pharmaceuticals

According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against otherwise hard to target biomolecules. In fact, many service provider companies are offering fragment libraries and support to the medical ... Read more

Submitted by Roots_Analysis on 2020-12-10 08:10.

The fragment-based drug discovery market is projected to grow at an annualized rate of ~10%, till 2030

Market-Research

Roots Analysis has done a detailed study on Fragment-based Drug Discovery Market: Library and Service ... Read more

Submitted by Roots_Analysis on 2020-12-10 08:09.

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis

Market-Research

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

Submitted by Roots_Analysis on 2020-12-10 08:08.

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China.

Market-Research

To order this detailed 250+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-12-04 09:19.

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis

Pharmaceuticals

Owing to benefits, such as reduced manufacturing costs, availability of cheap and skilled labor, and a supportive regulatory landscape, biopharmaceutical developers from across the globe, are increasingly outsourcing their manufacturing operations to China based CMOs. Further, in

Submitted by Roots_Analysis on 2020-12-04 09:18.

The Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030

Market-Research

Roots Analysis has done a detailed study on China Biopharmaceutical Contract Manufacturing Market, 2020-2030, covering key ... Read more

Submitted by Roots_Analysis on 2020-12-04 09:17.

The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis

Market-Research

The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years

Submitted by Roots_Analysis on 2020-12-04 09:16.

The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030” features an extensive study of the current market landscape and future opportunities associated with manufacturing of cell therapies.

Market-Research

To order this 550+ page report, please visit this link

Key Inclusions

A detailed review of

Submitted by Roots_Analysis on 2020-12-04 09:16.

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis

Market-Research

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be

Submitted by Roots_Analysis on 2020-12-04 09:15.

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3^rd Edition), 2019 - 2030, ... Read more

Submitted by Roots_Analysis on 2020-12-04 09:14.

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, predicts Roots Analysis

Market-Research

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers

Submitted by Roots_Analysis on 2020-12-04 09:13.

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis

Market-Research

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Submitted by Roots_Analysis on 2020-12-04 09:07.

The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study of the innovative software solutions that are being used to improve / optimize various supply chain-related processes of cell and advanced thera

Market-Research

The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study of the innovative software solutions that are being used to improve / optimize various supply chain-related processes of cell and advanced therapies. Read more

Submitted by Roots_Analysis on 2020-12-03 08:46.

Presently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies

Pharmaceuticals

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to ... Read more

Submitted by Roots_Analysis on 2020-12-03 08:37.

Given the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030

Market-Research

Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell ... Read more

Submitted by Roots_Analysis on 2020-12-03 08:35.

Companion Diagnostics Development Services Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade. It features an i

Market-Research

To order this detailed 320+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-12-02 09:09.

Over 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic tests, claims Roots Analysis

Market-Research

It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house expertise. On the other hand, there are numerous contract service providers, offering vast portfolios of services for

Submitted by Roots_Analysis on 2020-12-02 09:07.

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunities

To order this 320+

Submitted by Roots_Analysis on 2020-12-02 09:07.

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis

Pharmaceuticals

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

Submitted by Roots_Analysis on 2020-12-02 09:06.

Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3

Market-Research

To order this detailed 370+ page report, please visit this link

Key ... Read more

Submitted by Roots_Analysis on 2020-12-02 09:02.

Pages